| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 5.42e-05 | 188 | 103 | 7 | GO:0005201 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 9.22e-05 | 46 | 103 | 4 | GO:0030020 | |
| GeneOntologyMolecularFunction | hypoxia-inducible factor-proline dioxygenase activity | 1.57e-04 | 4 | 103 | 2 | GO:0160082 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | EVL HSPG2 ATG9B COL11A1 DSCAM EGLN1 EXT1 RYR2 PRDM1 FAM20C ARID5B CD44 OLFM1 TRPV4 PAX9 CTSV WNK4 FOXF1 COL1A1 | 1.49e-05 | 1269 | 103 | 19 | GO:0009887 |
| GeneOntologyBiologicalProcess | extracellular matrix organization | MPV17 HSPG2 COL11A1 COL12A1 EXT1 HMCN1 COL14A1 CTSV FOXF1 COL1A1 | 1.93e-05 | 377 | 103 | 10 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | MPV17 HSPG2 COL11A1 COL12A1 EXT1 HMCN1 COL14A1 CTSV FOXF1 COL1A1 | 1.97e-05 | 378 | 103 | 10 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | MPV17 HSPG2 COL11A1 COL12A1 EXT1 HMCN1 COL14A1 CTSV FOXF1 COL1A1 | 2.02e-05 | 379 | 103 | 10 | GO:0045229 |
| GeneOntologyBiologicalProcess | collagen fibril organization | 3.93e-05 | 76 | 103 | 5 | GO:0030199 | |
| GeneOntologyBiologicalProcess | cartilage development involved in endochondral bone morphogenesis | 8.87e-05 | 47 | 103 | 4 | GO:0060351 | |
| GeneOntologyBiologicalProcess | dendrite self-avoidance | 9.34e-05 | 18 | 103 | 3 | GO:0070593 | |
| GeneOntologyBiologicalProcess | head morphogenesis | 9.64e-05 | 48 | 103 | 4 | GO:0060323 | |
| GeneOntologyCellularComponent | anchoring collagen complex | 7.33e-05 | 3 | 104 | 2 | GO:0030934 | |
| GeneOntologyCellularComponent | anchoring junction | JCAD EVL HSPG2 AOC1 CNTNAP1 FRMD4B LLGL2 EFNA5 HMCN1 SORBS3 CD44 NHS TRPV4 WNK4 | 3.38e-04 | 976 | 104 | 14 | GO:0070161 |
| GeneOntologyCellularComponent | FACIT collagen trimer | 3.63e-04 | 6 | 104 | 2 | GO:0005593 | |
| GeneOntologyCellularComponent | tight junction | 6.56e-04 | 139 | 104 | 5 | GO:0070160 | |
| GeneOntologyCellularComponent | adherens junction | 6.74e-04 | 212 | 104 | 6 | GO:0005912 | |
| GeneOntologyCellularComponent | cell-cell junction | 7.29e-04 | 591 | 104 | 10 | GO:0005911 | |
| GeneOntologyCellularComponent | collagen trimer | 9.78e-04 | 88 | 104 | 4 | GO:0005581 | |
| GeneOntologyCellularComponent | apical junction complex | 1.17e-03 | 158 | 104 | 5 | GO:0043296 | |
| GeneOntologyCellularComponent | fibrillar collagen trimer | 1.57e-03 | 12 | 104 | 2 | GO:0005583 | |
| GeneOntologyCellularComponent | banded collagen fibril | 1.57e-03 | 12 | 104 | 2 | GO:0098643 | |
| GeneOntologyCellularComponent | external encapsulating structure | HSPG2 COL11A1 COL12A1 CHI3L1 PKHD1L1 EFNA5 HMCN1 COL14A1 CTSV COL1A1 | 1.63e-03 | 658 | 104 | 10 | GO:0030312 |
| GeneOntologyCellularComponent | P-body | 1.69e-03 | 102 | 104 | 4 | GO:0000932 | |
| HumanPheno | Bowing of the long bones | HSPG2 COL11A1 COL12A1 DYNC2H1 BAZ1B EXT1 FAM20C TRPV4 VPS13B WDR62 COL1A1 | 2.59e-05 | 316 | 41 | 11 | HP:0006487 |
| HumanPheno | Anomaly of the limb diaphyses | HSPG2 COL11A1 COL12A1 DYNC2H1 BAZ1B EXT1 FAM20C TRPV4 VPS13B WDR62 COL1A1 | 3.08e-05 | 322 | 41 | 11 | HP:0006504 |
| HumanPheno | Abnormal diaphysis morphology | HSPG2 COL11A1 COL12A1 DYNC2H1 BAZ1B EXT1 FAM20C TRPV4 VPS13B WDR62 COL1A1 | 5.54e-05 | 343 | 41 | 11 | HP:0000940 |
| HumanPheno | Malar flattening | HSPG2 COL11A1 BAZ1B MLXIPL FAM20C CNOT1 VPS13B DNMT3B COL1A1 | 9.17e-05 | 240 | 41 | 9 | HP:0000272 |
| HumanPheno | Abnormal malar bone morphology | HSPG2 COL11A1 BAZ1B MLXIPL FAM20C CNOT1 VPS13B DNMT3B COL1A1 | 1.22e-04 | 249 | 41 | 9 | HP:0012369 |
| HumanPheno | Abnormal zygomatic arch morphology | HSPG2 COL11A1 BAZ1B MLXIPL FAM20C CNOT1 VPS13B DNMT3B COL1A1 | 1.26e-04 | 250 | 41 | 9 | HP:0005557 |
| HumanPheno | Abnormal zygomatic bone morphology | HSPG2 COL11A1 BAZ1B MLXIPL FAM20C CNOT1 VPS13B DNMT3B COL1A1 | 1.26e-04 | 250 | 41 | 9 | HP:0010668 |
| HumanPheno | Bowing of the legs | 1.42e-04 | 254 | 41 | 9 | HP:0002979 | |
| MousePheno | abnormal muscle physiology | HSPG2 EGLN2 COL12A1 DSCAM CNTNAP1 ARHGEF12 XIAP RYR2 NEU2 CD44 MRPS34 COL14A1 TRPV4 TNKS AVPI1 ABHD12 CTSV COL1A1 | 3.06e-05 | 954 | 90 | 18 | MP:0002106 |
| MousePheno | postnatal lethality | RC3H2 DSCAM SREBF1 BAZ1B METTL23 ADCY3 RYR2 PRDM1 FAM20C LLGL2 EFNA5 ARID5B PAX9 TNKS2 UNC79 CTSV FOXF1 DNMT3B COL1A1 | 4.89e-05 | 1084 | 90 | 19 | MP:0002082 |
| MousePheno | abnormal head morphology | SMG1 HSPG2 COL11A1 RNF168 DSCAM DYNC2H1 BAZ1B METTL23 PRDM1 PTOV1 FAM20C EFNA5 ZFHX4 ARID5B PAX9 CTSV WDR62 DNMT3B COL1A1 | 7.60e-05 | 1120 | 90 | 19 | MP:0000432 |
| MousePheno | lethality during fetal growth through weaning, incomplete penetrance | HSPG2 RC3H2 COL12A1 DSCAM SREBF1 METTL23 ADCY3 RYR2 PRDM1 FAM20C LLGL2 ARID5B PAX9 TNKS2 UNC79 CTSV FOXF1 DNMT3B COL1A1 | 7.97e-05 | 1124 | 90 | 19 | MP:0011112 |
| MousePheno | postnatal lethality, incomplete penetrance | RC3H2 DSCAM SREBF1 METTL23 ADCY3 PRDM1 FAM20C LLGL2 PAX9 TNKS2 CTSV FOXF1 DNMT3B COL1A1 | 8.93e-05 | 669 | 90 | 14 | MP:0011086 |
| MousePheno | short nasal bone | 9.02e-05 | 37 | 90 | 4 | MP:0004471 | |
| MousePheno | abnormal mouth morphology | SMG1 HSPG2 COL11A1 DYNC2H1 BAZ1B PTOV1 FAM20C EFNA5 ZFHX4 ARID5B PAX9 CTSV DNMT3B COL1A1 | 9.07e-05 | 670 | 90 | 14 | MP:0000452 |
| MousePheno | absent plasma cells | 1.22e-04 | 3 | 90 | 2 | MP:0008100 | |
| MousePheno | abnormal dental pulp cavity morphology | 1.36e-04 | 16 | 90 | 3 | MP:0002819 | |
| Domain | Laminin_G | 1.93e-05 | 58 | 106 | 5 | IPR001791 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 1.14e-05 | 50 | 84 | 5 | MM14796 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 1.96e-05 | 140 | 84 | 7 | M587 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 3.05e-05 | 61 | 84 | 5 | M27103 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 8.83e-05 | 76 | 84 | 5 | MM14573 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 1.00e-04 | 41 | 84 | 4 | MM15538 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 1.33e-04 | 44 | 84 | 4 | M27812 | |
| Pathway | PID_SYNDECAN_1_PATHWAY | 1.58e-04 | 46 | 84 | 4 | M198 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 1.97e-04 | 90 | 84 | 5 | M631 | |
| Pubmed | 5.87e-09 | 8 | 107 | 4 | 18816857 | ||
| Pubmed | 2.82e-07 | 5 | 107 | 3 | 21613984 | ||
| Pubmed | JCAD EGLN2 HDAC6 DSCAM CNTNAP1 CCT7 PSMD7 ZNFX1 TUBGCP5 FRMD4B OSBPL1A ARID5B OLFM1 TOLLIP TNKS TNKS2 ABHD12 | 4.03e-07 | 1285 | 107 | 17 | 35914814 | |
| Pubmed | Deletion of Pax1 scoliosis-associated regulatory elements leads to a female-biased tail abnormality. | 5.62e-07 | 6 | 107 | 3 | 38461417 | |
| Pubmed | 5.93e-07 | 22 | 107 | 4 | 27521426 | ||
| Pubmed | AOC1 HDAC6 BAZ1B XIAP INO80 ADCY3 ZRANB3 VILL ARID5B TOLLIP PAN3 MGA CNOT1 VPS13B ZNF445 | 1.20e-06 | 1084 | 107 | 15 | 11544199 | |
| Pubmed | 1.24e-06 | 175 | 107 | 7 | 28071719 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | JCAD XIAP PSMD7 FAM83B RUSC2 PTOV1 MLXIPL STARD9 COBL NHS PAN3 WNK4 WDR62 | 2.55e-06 | 861 | 107 | 13 | 36931259 |
| Pubmed | SEL1L MPV17 JCAD RC3H2 COL11A1 DYNC2H1 SREBF1 BAZ1B CCT7 CD44 COBL MGA | 3.74e-06 | 754 | 107 | 12 | 35906200 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 4.11e-06 | 398 | 107 | 9 | 35016035 | |
| Pubmed | 6.41e-06 | 39 | 107 | 4 | 33580754 | ||
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 7.17e-06 | 86 | 107 | 5 | 28327460 | |
| Pubmed | SMG1 HSPG2 BAZ1B IRF4 CCT7 PSMD7 INO80 PRDM1 ZFHX4 ARID5B MRPS34 PAX9 PAN3 MGA TADA3 CNOT1 | 7.75e-06 | 1429 | 107 | 16 | 35140242 | |
| Pubmed | EGR1 and EGR2 involvement in vertebrate tendon differentiation. | 7.92e-06 | 13 | 107 | 3 | 21173153 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 19306436 | ||
| Pubmed | Tankyrase is necessary for canonical Wnt signaling during kidney development. | 9.38e-06 | 2 | 107 | 2 | 20549720 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 24606892 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 24606891 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 15609093 | ||
| Pubmed | Tankyrase Requires SAM Domain-Dependent Polymerization to Support Wnt-β-Catenin Signaling. | 9.38e-06 | 2 | 107 | 2 | 27494558 | |
| Pubmed | The HDAC6/APOBEC3G complex regulates HIV-1 infectiveness by inducing Vif autophagic degradation. | 9.38e-06 | 2 | 107 | 2 | 26105074 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 34920653 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 37783295 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 19631610 | ||
| Pubmed | Regulation of tankyrase activity by a catalytic domain dimer interface. | 9.38e-06 | 2 | 107 | 2 | 30055800 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 28594552 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 17960519 | ||
| Pubmed | Endothelial prolyl hydroxylase 2 is necessary for angiotensin II-mediated renal fibrosis and injury. | 9.38e-06 | 2 | 107 | 2 | 32715763 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 30165890 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 29148820 | ||
| Pubmed | Molecular insights on TNKS1/TNKS2 and inhibitor-IWR1 interactions. | 9.38e-06 | 2 | 107 | 2 | 24291818 | |
| Pubmed | Tankyrase 1 and tankyrase 2 are essential but redundant for mouse embryonic development. | 9.38e-06 | 2 | 107 | 2 | 18612384 | |
| Pubmed | Proteomic Analysis of the Human Tankyrase Protein Interaction Network Reveals Its Role in Pexophagy. | 9.38e-06 | 2 | 107 | 2 | 28723574 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 30935969 | ||
| Pubmed | Abnormal corneal endothelial maturation in collagen XII and XIV null mice. | 9.38e-06 | 2 | 107 | 2 | 23599329 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 18026951 | ||
| Pubmed | Structural insights into SAM domain-mediated tankyrase oligomerization. | 9.38e-06 | 2 | 107 | 2 | 27328430 | |
| Pubmed | Discovery of tankyrase inhibiting flavones with increased potency and isoenzyme selectivity. | 9.38e-06 | 2 | 107 | 2 | 24116873 | |
| Pubmed | Expression of type I and XII collagen during development of the periodontal ligament in the mouse. | 9.38e-06 | 2 | 107 | 2 | 9796779 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 29335275 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 15795250 | ||
| Pubmed | A chondroitin/dermatan sulfate form of CD44 is a receptor for collagen XIV (undulin). | 9.38e-06 | 2 | 107 | 2 | 8986622 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 2824282 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 34110284 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 25263965 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 29263426 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 24559391 | ||
| Pubmed | 1.06e-05 | 568 | 107 | 10 | 9110174 | ||
| Pubmed | A "double adaptor" method for improved shotgun library construction. | 1.16e-05 | 574 | 107 | 10 | 8619474 | |
| Pubmed | 1.50e-05 | 100 | 107 | 5 | 26073538 | ||
| Pubmed | Ontogeny of stromal organizer cells during lymph node development. | 1.54e-05 | 16 | 107 | 3 | 20237296 | |
| Pubmed | Laminin-511 and integrin beta-1 in hair follicle development and basal cell carcinoma formation. | 1.54e-05 | 16 | 107 | 3 | 21067603 | |
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 23690557 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 32814068 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 32442396 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 30248340 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 21887331 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 24508125 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 27502280 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 27841661 | ||
| Pubmed | Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation. | 2.81e-05 | 3 | 107 | 2 | 22343896 | |
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 24195777 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 20959442 | ||
| Pubmed | Genetic variation in genes of the fatty acid synthesis pathway and breast cancer risk. | 2.81e-05 | 3 | 107 | 2 | 19252981 | |
| Pubmed | Mammalian EGLN genes have distinct patterns of mRNA expression and regulation. | 2.81e-05 | 3 | 107 | 2 | 12234095 | |
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 24591370 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 21145868 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 26774962 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 24037093 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 11595184 | ||
| Pubmed | HIF-1, O(2), and the 3 PHDs: how animal cells signal hypoxia to the nucleus. | 2.81e-05 | 3 | 107 | 2 | 11595178 | |
| Pubmed | Role for the related poly(ADP-Ribose) polymerases tankyrase 1 and 2 at human telomeres. | 2.81e-05 | 3 | 107 | 2 | 11739745 | |
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 21877141 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 24711583 | ||
| Pubmed | Lack of activity of recombinant HIF prolyl hydroxylases (PHDs) on reported non-HIF substrates. | 2.81e-05 | 3 | 107 | 2 | 31500697 | |
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 17044072 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 25939383 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 24990963 | ||
| Pubmed | Loss of the oxygen sensor PHD3 enhances the innate immune response to abdominal sepsis. | 2.81e-05 | 3 | 107 | 2 | 22786772 | |
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 36081178 | ||
| Pubmed | The HDAC6-RNF168 axis regulates H2A/H2A.X ubiquitination to enable double-strand break repair. | 2.81e-05 | 3 | 107 | 2 | 37503842 | |
| Pubmed | Arpin Regulates Migration Persistence by Interacting with Both Tankyrases and the Arp2/3 Complex. | 2.81e-05 | 3 | 107 | 2 | 33923443 | |
| Pubmed | Opposing regulation and roles for PHD3 in lung dendritic cells and alveolar macrophages. | 2.81e-05 | 3 | 107 | 2 | 28716863 | |
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 11454873 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 22615432 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 21251231 | ||
| Pubmed | Prolyl hydroxylase domain proteins regulate bone mass through their expression in osteoblasts. | 2.81e-05 | 3 | 107 | 2 | 27614241 | |
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 18235046 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 20600011 | ||
| Pubmed | Molecular oxygen sensing: implications for visceral surgery. | 2.81e-05 | 3 | 107 | 2 | 22395314 | |
| Pubmed | The HIF-prolyl hydroxylases have distinct and nonredundant roles in colitis-associated cancer. | 2.81e-05 | 3 | 107 | 2 | 36509284 | |
| Pubmed | Characterization and comparative analysis of the EGLN gene family. | 2.81e-05 | 3 | 107 | 2 | 11574160 | |
| Pubmed | Structural basis for oxygen degradation domain selectivity of the HIF prolyl hydroxylases. | 2.81e-05 | 3 | 107 | 2 | 27561929 | |
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 22262480 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 26246473 | ||
| Pubmed | WNK kinases influence TRPV4 channel function and localization. | 2.81e-05 | 3 | 107 | 2 | 16403833 | |
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 28027934 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 27981571 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 24056747 | ||
| Pubmed | Increased DNA methylation of Dnmt3b targets impairs leukemogenesis. | 2.81e-05 | 3 | 107 | 2 | 26729896 | |
| Interaction | TNKS1BP1 interactions | 2.58e-06 | 168 | 104 | 8 | int:TNKS1BP1 | |
| Cytoband | 3p26-p25 | 1.61e-05 | 3 | 107 | 2 | 3p26-p25 | |
| GeneFamily | Collagens | 3.91e-05 | 46 | 75 | 4 | 490 | |
| GeneFamily | Blood group antigens|CD molecules|Proteoglycans | 3.52e-04 | 7 | 75 | 2 | 570 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 5.50e-04 | 161 | 75 | 5 | 593 | |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 2.22e-03 | 17 | 75 | 2 | 684 | |
| GeneFamily | Ankyrin repeat domain containing | 3.32e-03 | 242 | 75 | 5 | 403 | |
| GeneFamily | PWWP domain containing | 3.72e-03 | 22 | 75 | 2 | 1147 | |
| GeneFamily | Fibronectin type III domain containing | 4.41e-03 | 160 | 75 | 4 | 555 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_LUNG_TUMOR | 1.25e-05 | 35 | 107 | 4 | MM17054 | |
| Coexpression | XU_GH1_AUTOCRINE_TARGETS_DN | 1.66e-05 | 131 | 107 | 6 | M16384 | |
| Coexpression | NABA_COLLAGENS | 2.87e-05 | 43 | 107 | 4 | MM17060 | |
| Coexpression | NABA_COLLAGENS | 3.14e-05 | 44 | 107 | 4 | M3005 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#1_top-relative-expression-ranked_100 | 4.94e-07 | 33 | 102 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_100_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#5_top-relative-expression-ranked_200 | 9.94e-07 | 69 | 102 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_200_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_100 | 3.65e-06 | 86 | 102 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_100 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_top-relative-expression-ranked_1000 | SEL1L SMG1 HDAC6 BAZ1B XIAP INO80 FAM20C LLGL2 VILL MRPS34 TRPV4 TNKS2 ABHD12 WNK4 VPS13B | 5.12e-06 | 786 | 102 | 15 | gudmap_developingKidney_e15.5_Medullary collecting duct_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#2_top-relative-expression-ranked_500 | 7.65e-06 | 209 | 102 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_top-relative-expression-ranked_200 | 1.56e-05 | 166 | 102 | 7 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_200 | 1.56e-05 | 166 | 102 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#3_top-relative-expression-ranked_100 | 2.08e-05 | 34 | 102 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_100_k3 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_500 | RC3H2 COL11A1 FRMD4B STARD9 ARID5B CD44 COL14A1 MGA COL1A1 ZNF445 | 2.50e-05 | 404 | 102 | 10 | gudmap_developingGonad_e18.5_epididymis_500 |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_top-relative-expression-ranked_200 | 2.53e-05 | 179 | 102 | 7 | gudmap_developingGonad_e11.5_testes and mesonephros_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_top-relative-expression-ranked_500 | 3.47e-05 | 420 | 102 | 10 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#5_top-relative-expression-ranked_200 | 3.70e-05 | 78 | 102 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_200_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_100 | 5.00e-05 | 83 | 102 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_100 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k-means-cluster#3_top-relative-expression-ranked_1000 | 7.77e-05 | 91 | 102 | 5 | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k3_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_1000 | SEL1L BAZ1B XIAP MANEA CNTN6 ZFHX4 CD44 COBL SHE COL14A1 TNKS2 FOXF1 COL1A1 | 8.31e-05 | 772 | 102 | 13 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000 |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#1_top-relative-expression-ranked_100 | 9.86e-05 | 19 | 102 | 3 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k1_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.00e-04 | 385 | 102 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 | |
| CoexpressionAtlas | dev gonad_e13.5_F_DevVascOvary_Flk_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.05e-04 | 51 | 102 | 4 | gudmap_dev gonad_e13.5_F_gudmap_devVascOvary_Flk_k4_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_1000 | SEL1L SMG1 RC3H2 BAZ1B XIAP INO80 MLXIPL COL14A1 TNKS TNKS2 MGA WNK4 VPS13B | 1.11e-04 | 795 | 102 | 13 | gudmap_developingKidney_e15.5_anlage of loop of Henle_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.19e-04 | 159 | 102 | 6 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_1000_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#1_top-relative-expression-ranked_500 | 1.27e-04 | 231 | 102 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_500_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_1000 | SEL1L SMG1 BAZ1B XIAP RYR2 ZFHX4 ARID5B COBL SHE COL14A1 TNKS2 FOXF1 COL1A1 | 1.36e-04 | 811 | 102 | 13 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#5_top-relative-expression-ranked_500 | 1.46e-04 | 165 | 102 | 6 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k5_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | SMG1 BAZ1B XIAP RYR2 EFNA5 ZFHX4 OLFM1 COL14A1 TNKS TNKS2 ABHD12 VPS13B FOXF1 | 1.48e-04 | 818 | 102 | 13 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.61e-04 | 168 | 102 | 6 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k2_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_200 | 1.78e-04 | 171 | 102 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_500 | 1.79e-04 | 416 | 102 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_500 | 1.96e-04 | 421 | 102 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.32e-04 | 339 | 102 | 8 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_500_k-means-cluster#5 | 2.44e-04 | 116 | 102 | 5 | ratio_EB_vs_SC_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#2 | 2.58e-04 | 437 | 102 | 9 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K2 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.68e-04 | 261 | 102 | 7 | gudmap_developingKidney_e15.5_Medullary collecting duct_1000_k4 | |
| CoexpressionAtlas | BM Top 100 - endometrium | 2.88e-04 | 66 | 102 | 4 | BM Top 100 - endometrium | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#1_top-relative-expression-ranked_1000 | 3.32e-04 | 124 | 102 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#2_top-relative-expression-ranked_1000 | 4.24e-04 | 73 | 102 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k2 | |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_k-means-cluster#1_top-relative-expression-ranked_100 | 4.39e-04 | 31 | 102 | 3 | gudmap_developingKidney_e13.5_podocyte cells_100_k1 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | SMG1 RC3H2 COL11A1 COL12A1 FRMD4B STARD9 ARID5B CD44 COL14A1 MGA COL1A1 ZNF445 | 4.50e-04 | 799 | 102 | 12 | gudmap_developingGonad_e18.5_epididymis_1000 |
| CoexpressionAtlas | kidney_P1_CapMes_Crym_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.70e-04 | 75 | 102 | 4 | gudmap_kidney_P1_CapMes_Crym_k3_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.88e-04 | 379 | 102 | 8 | gudmap_developingKidney_e15.5_1000_k3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_top-relative-expression-ranked_1000 | SEL1L RNF168 BAZ1B XIAP MANEA ADCY3 CNTN6 SHE COL14A1 TNKS TNKS2 COL1A1 | 5.02e-04 | 809 | 102 | 12 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | SMG1 RNF168 DYNC2H1 ARHGEF12 BAZ1B XIAP FRMD4B ZRANB3 TNKS2 ZNF445 | 5.84e-04 | 595 | 102 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_top-relative-expression-ranked_1000 | COL12A1 BAZ1B RYR2 CNTN6 ZFHX4 COBL SHE COL14A1 TNKS TNKS2 FOXF1 COL1A1 | 6.78e-04 | 837 | 102 | 12 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_1000 |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_induced-Mesoderm_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000 | DSCAM SOWAHD SH2D3A APOBEC3G MANEA PRDM1 MLXIPL LLGL2 COBL TRPV4 UNC79 CTSV DNMT3B | 7.46e-04 | 969 | 102 | 13 | PCBC_MESO-5_fibroblast_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_stage III -IV renal corpusc_emap-27945_k-means-cluster#5_top-relative-expression-ranked_1000 | 7.83e-04 | 226 | 102 | 6 | gudmap_developingKidney_e15.5_stage III -IV renal corpusc_1000_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_top-relative-expression-ranked_100 | 7.88e-04 | 86 | 102 | 4 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_100 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K1 | 7.90e-04 | 150 | 102 | 5 | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K1 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#4_top-relative-expression-ranked_500 | 8.39e-04 | 152 | 102 | 5 | gudmap_developingGonad_e18.5_epididymis_500_k4 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | 8.54e-04 | 413 | 102 | 8 | gudmap_developingGonad_e14.5_ epididymis_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | RNF168 DYNC2H1 ARHGEF12 BAZ1B XIAP TMEM200A ZRANB3 TNKS2 MGA ZNF445 | 8.94e-04 | 629 | 102 | 10 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_top-relative-expression-ranked_100 | 8.96e-04 | 89 | 102 | 4 | gudmap_developingKidney_e13.5_podocyte cells_100 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_500 | 9.43e-04 | 156 | 102 | 5 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_500_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_top-relative-expression-ranked_500 | 9.81e-04 | 422 | 102 | 8 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#1_top-relative-expression-ranked_200 | 1.01e-03 | 92 | 102 | 4 | gudmap_developingGonad_e11.5_testes and mesonephros_k1_200 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_k-means-cluster#1_top-relative-expression-ranked_500 | 1.07e-03 | 240 | 102 | 6 | gudmap_kidney_adult_RenalCapsule_k1_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.07e-03 | 330 | 102 | 7 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29977_top-relative-expression-ranked_1000 | SEL1L JCAD HSPG2 BAZ1B XIAP INO80 FRMD4B PRDM1 SHE TNKS2 DNMT3B | 1.11e-03 | 764 | 102 | 11 | DevelopingKidney_e15.5_Endothelial cells_emap-29977_1000 |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_top-relative-expression-ranked_500 | 1.19e-03 | 435 | 102 | 8 | gudmap_developingGonad_e11.5_testes and mesonephros_500 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#3_top-relative-expression-ranked_200 | 1.24e-03 | 44 | 102 | 3 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k3_200 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.61e-09 | 165 | 107 | 8 | 6d315e0734079ad05336cc2c3f24d870c9105bc8 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.61e-09 | 165 | 107 | 8 | 84f5597b1bb75f42de9a224196bb8ac198bbe3bf | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-08 | 184 | 107 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-08 | 184 | 107 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-08 | 184 | 107 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.64e-08 | 197 | 107 | 8 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-07 | 160 | 107 | 7 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-07 | 160 | 107 | 7 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | T_cells-Resident_memory_CD8+_T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 3.15e-07 | 184 | 107 | 7 | e04cabff33a8e36967622ec3e5b37b89afa7e148 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-4|TCGA-Prostate / Sample_Type by Project: Shred V9 | 4.66e-07 | 195 | 107 | 7 | 5562665dd3beb70e2358aa32611a337bef5731c1 | |
| ToppCell | Fibroblasts-HLA-DRA_high_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 5.17e-07 | 198 | 107 | 7 | e8c0fbf306fae13e97caa294d7c99a564bd97130 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.35e-07 | 199 | 107 | 7 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.53e-07 | 200 | 107 | 7 | 8827653738a931e4a4545e0c7d75be12bed40740 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 5.53e-07 | 200 | 107 | 7 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | Basal_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 2.85e-06 | 164 | 107 | 6 | b15a26130a1ea1b370b6e3be21f02a0d6aaf6b3c | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.88e-06 | 173 | 107 | 6 | 8888434641ea554a9b62c436e87920378eef29cd | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.01e-06 | 174 | 107 | 6 | 015d3742d3d79a57413a333f00ef2d380a9848dd | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.72e-06 | 179 | 107 | 6 | ce3ca7f3a5864e62307aa744a3173f350a90df28 | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-OMD+_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.72e-06 | 179 | 107 | 6 | 8c9ed247e1c4d655b81ce2f24a9936a7cade718a | |
| ToppCell | Adult-Epithelial-basal_cell|Adult / Lineage, Cell type, age group and donor | 5.36e-06 | 183 | 107 | 6 | 00a6b19ca49e3b8e0d1cd387a3515b0ff4b81c81 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.36e-06 | 183 | 107 | 6 | dc19857b66dcadbf7c87de91f7b1f4e8ef2857ed | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.36e-06 | 183 | 107 | 6 | 4759560e5b4f4e5a00e5f933e3451a27c7c4aefe | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.53e-06 | 184 | 107 | 6 | d33de57876817050b294f2ecb0a4eb0634cfa7f0 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor | 5.71e-06 | 185 | 107 | 6 | 32b4e68e551d435a732f253f6ad83408c759a642 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.89e-06 | 186 | 107 | 6 | 56c139e679d640ea901ead657a8e8887e0fca098 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.07e-06 | 187 | 107 | 6 | 3ae3b8de1a195d4d5057cf3c64fcdb5f48681ce5 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.07e-06 | 187 | 107 | 6 | f124d2c699b717b7c02a1a70493f515b83dc2f4c | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 6.07e-06 | 187 | 107 | 6 | a96495803ba13fcfadd1d83b3cf5774f3fed0a20 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.45e-06 | 189 | 107 | 6 | eccf3d49354a67c94f1ed7c15a98a48a5e8e2ed0 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.45e-06 | 189 | 107 | 6 | e32172ad09e93f6ac6ea2b92145b2b73003f7970 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.45e-06 | 189 | 107 | 6 | 40764f461b8aa1d3a2c5a30590b7fb9307d47d09 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_macrophage-stroma-erythroid_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.65e-06 | 190 | 107 | 6 | cf463b2f227f3cc7d3fd296c810c0cbe51cbee72 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.65e-06 | 190 | 107 | 6 | d6b3a92119b210974a32af3fe9875d60eb02761e | |
| ToppCell | P07|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.65e-06 | 190 | 107 | 6 | 38a613a9bca0ba040c3ada00286d1ce6f83ab23a | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.85e-06 | 191 | 107 | 6 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.85e-06 | 191 | 107 | 6 | 5271198116343c07202649889057e5774d7fdde3 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.85e-06 | 191 | 107 | 6 | 08720998aa55131d7377c4c67c4c935865bd7d79 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.85e-06 | 191 | 107 | 6 | 156b467187331ac6ca390d6ca861d9670bb7b956 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.85e-06 | 191 | 107 | 6 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.85e-06 | 191 | 107 | 6 | 44b1f62fdee03b157fe545f2ae6ff84f8929a8ac | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.06e-06 | 192 | 107 | 6 | 67e845e513e76e820f55e2f0d15eb16f2944d05c | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 7.27e-06 | 193 | 107 | 6 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.27e-06 | 193 | 107 | 6 | 82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.71e-06 | 195 | 107 | 6 | 6c9c58322c1df891bb4bab56dacb542c8777bb7d | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.71e-06 | 195 | 107 | 6 | fee9d13f48149cd5f921cfe4b8b3053cf6a6dbd2 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.94e-06 | 196 | 107 | 6 | 22767bcf0095d9eb0cbed7cdc74e4d32d9357e1b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.94e-06 | 196 | 107 | 6 | 145fcf73deba9638b391a1af6c39fa205dc9829f | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.94e-06 | 196 | 107 | 6 | adee900dcd16dbaba15c58bdcace09ba20214950 | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | 7.94e-06 | 196 | 107 | 6 | 275e153347caf94edc0c50021bbab49c8696fecb | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 8.17e-06 | 197 | 107 | 6 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | distal-1-Hematologic-Plasma|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.17e-06 | 197 | 107 | 6 | f5499bfa9dbc111f12563b7006bc45c2423ad0cd | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.17e-06 | 197 | 107 | 6 | 107cb153ea7fc74bbd244dbb9d0499c0a8506724 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.17e-06 | 197 | 107 | 6 | 1e915957ea6a4550ecb9d6ee4b232aa5800faf20 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.17e-06 | 197 | 107 | 6 | 63b63c6b2f842adb87bc83222ff86796bd9b58f6 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.17e-06 | 197 | 107 | 6 | fb50903b87498b400c8e16e6a561b6d9458e5d97 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.41e-06 | 198 | 107 | 6 | 2f03f8897dd7cce6d8296638e14e11ec16bcf624 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_4_(MMP1+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.41e-06 | 198 | 107 | 6 | 229588189825b1080181db9515185677b742c668 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.41e-06 | 198 | 107 | 6 | bc9c9f2c87282b5ef8514773e065d2a6b5dde338 | |
| ToppCell | facs-Tongue-nan-3m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.41e-06 | 198 | 107 | 6 | f2a4057f038ef7225a5b98a7ab068c30dff4eadd | |
| ToppCell | distal-Epithelial-Basal-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.41e-06 | 198 | 107 | 6 | dda0bf3a48f738df590ce23b891d82be19e10d66 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.41e-06 | 198 | 107 | 6 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.66e-06 | 199 | 107 | 6 | ba586690f88fd051f449753bfe7603a2cb431782 | |
| ToppCell | Bronchial-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.66e-06 | 199 | 107 | 6 | a13f4b8a039304e685464cc8879659824cad5a3e | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.66e-06 | 199 | 107 | 6 | 38ed3bc7daa993d9edcf3e7834597ebb06dd24f8 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.66e-06 | 199 | 107 | 6 | 06a7d874ff7c4616577f6e59d3118717a8c47c00 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.66e-06 | 199 | 107 | 6 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | 8.66e-06 | 199 | 107 | 6 | 211c3a08f2d484ab7a3368006767289088f0d957 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Proliferative_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.66e-06 | 199 | 107 | 6 | b65fbfed4a9938820cf900afd350b4ecb789b7b3 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.66e-06 | 199 | 107 | 6 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.66e-06 | 199 | 107 | 6 | 83383d9ae4f501754fd3da0215ce6f0e3c70562c | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.66e-06 | 199 | 107 | 6 | e1849505b92820a219c5a2c35492bdd55579fb48 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts|LPS_only / Treatment groups by lineage, cell group, cell type | 8.66e-06 | 199 | 107 | 6 | 1a0add79f4e34078b3475eb11c85a4234bda197c | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.66e-06 | 199 | 107 | 6 | 63c01e8961f48ed1bed4ab619cacf318cd6de7b9 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.91e-06 | 200 | 107 | 6 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.91e-06 | 200 | 107 | 6 | a4ec0e80f5422b91b85264a9bb74568dd577e285 | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.91e-06 | 200 | 107 | 6 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 8.91e-06 | 200 | 107 | 6 | 4f7e26b27bd51c32420ed8c2f52d070aee542159 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD8-Trm/em_CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.56e-05 | 144 | 107 | 5 | a4bb274d553c29c8299354de757ecc5634008c68 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_and_Lobular_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 3.02e-05 | 149 | 107 | 5 | 3904f8ce9078de238600ceceee0116af52256a1c | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.53e-05 | 154 | 107 | 5 | 37765512dfae557b9f6eb30a29463b93682a4404 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.64e-05 | 155 | 107 | 5 | c58a5fb8d853f12204e961d633e83452eb12a659 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.64e-05 | 155 | 107 | 5 | 9cb8c42c2e451b2d4dcd7154a4b1bfd21bbb7ea8 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.11e-05 | 159 | 107 | 5 | 7ed659163f45e0c4df4782997c0786900c8186c8 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.11e-05 | 159 | 107 | 5 | d3f81ba22160568ccaa6d2b04ebfd30630f9a6db | |
| ToppCell | (1)_Control_(PBS)-(4)_COL2.3+_osteoblasts|World / Stress and Cell class | 4.24e-05 | 160 | 107 | 5 | ab769516f9f7798d1390ef215caf22a2d3d53e63 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.50e-05 | 162 | 107 | 5 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-Tregs|bone_marrow / Manually curated celltypes from each tissue | 4.91e-05 | 165 | 107 | 5 | 1ae1ad4e1fe19b6eefff0f9a03d58a384f169759 | |
| ToppCell | Control-Epithelial_airway-Club_cells-Airway|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.35e-05 | 168 | 107 | 5 | ce87981f4da2779de952c2e5d2bbcdabb265e705 | |
| ToppCell | Control-Epithelial_airway-Club_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.35e-05 | 168 | 107 | 5 | e85bc5398eb36b2b0773a8a7082e3ba740452165 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.50e-05 | 169 | 107 | 5 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.65e-05 | 170 | 107 | 5 | 330b5fc8fde307eda9dcc7bc9053ea8a7e1f0f6d | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.65e-05 | 170 | 107 | 5 | 0c9d38e89b048166b879e6b4bdf7c5dfe8ab57c4 | |
| ToppCell | Control-Epithelial_cells-Airway_basal|Control / group, cell type (main and fine annotations) | 5.81e-05 | 171 | 107 | 5 | 3965ced4be6db14265a90673502fceee425837ca | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.81e-05 | 171 | 107 | 5 | a4a2c5dc995589fbe3d4ca6ee1df888807e4ae34 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.81e-05 | 171 | 107 | 5 | f5014e3c387fe3118944af392abe10d6b9b0abab | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.81e-05 | 171 | 107 | 5 | 5d31fc9b60329d4ae3c77e4ca679359d9314397d | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 5.81e-05 | 171 | 107 | 5 | bdd30100b74e012eec3090799c22635aa57fa91d | |
| ToppCell | E12.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.98e-05 | 172 | 107 | 5 | 3b9be685fcd1634498a603b692f5ac6ddd0de176 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.14e-05 | 173 | 107 | 5 | 30d67738633493d47f06ae452424382f069b6c0a | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.31e-05 | 174 | 107 | 5 | 99d7421ad5eafe7751ef90698a92f683aa33bca8 | |
| Drug | Meticrane [1084-65-7]; Up 200; 14.6uM; PC3; HT_HG-U133A | 3.15e-07 | 192 | 107 | 9 | 1792_UP | |
| Drug | Canrenoic acid potassium salt [2181-04-6]; Up 200; 10uM; MCF7; HT_HG-U133A | 4.26e-07 | 199 | 107 | 9 | 6783_UP | |
| Drug | malotilate | 1.05e-06 | 71 | 107 | 6 | CID000004006 | |
| Drug | Promazine hydrochloride [53-60-1]; Up 200; 12.4uM; HL60; HT_HG-U133A | 4.43e-06 | 198 | 107 | 8 | 2173_UP | |
| Drug | 4-hydroxyproline | 4.51e-06 | 91 | 107 | 6 | CID000000825 | |
| Drug | Gibberellic acid [77-06-5]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 4.60e-06 | 199 | 107 | 8 | 7330_DN | |
| Drug | L-lysyl-L-lysyl-L-lysine | 1.16e-05 | 162 | 107 | 7 | CID000072363 | |
| Drug | AC1L1C2F | 1.35e-05 | 110 | 107 | 6 | CID000001711 | |
| Drug | BAPN | 2.12e-05 | 71 | 107 | 5 | CID000001647 | |
| Drug | GK-101 | 2.42e-05 | 36 | 107 | 4 | CID000161853 | |
| Drug | hyaluronan | 3.47e-05 | 263 | 107 | 8 | CID000024759 | |
| Drug | SR-95639A [115767-94-7]; Up 200; 10uM; HL60; HT_HG-U133A | 3.60e-05 | 193 | 107 | 7 | 1336_UP | |
| Drug | Danazol [17230-88-5]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 3.60e-05 | 193 | 107 | 7 | 5315_UP | |
| Drug | 2-propylpentanoic acid; Down 200; 500uM; HL60; HT_HG-U133A | 3.72e-05 | 194 | 107 | 7 | 6199_DN | |
| Drug | Panthenol (D) [81-13-0]; Up 200; 19.4uM; HL60; HT_HG-U133A | 3.84e-05 | 195 | 107 | 7 | 1844_UP | |
| Drug | Metyrapone [54-36-4]; Up 200; 17.6uM; HL60; HT_HG-U133A | 3.97e-05 | 196 | 107 | 7 | 3070_UP | |
| Drug | Sulfadiazine [68-35-9]; Down 200; 16uM; MCF7; HT_HG-U133A | 3.97e-05 | 196 | 107 | 7 | 5523_DN | |
| Drug | Trioxsalen [3902-71-4]; Up 200; 17.6uM; HL60; HT_HG-U133A | 4.10e-05 | 197 | 107 | 7 | 2516_UP | |
| Drug | Benfotiamine [22457-89-2]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 4.10e-05 | 197 | 107 | 7 | 3931_DN | |
| Drug | (-)-MK 801 hydrogen maleate [77086-19-2]; Up 200; 11.8uM; PC3; HT_HG-U133A | 4.23e-05 | 198 | 107 | 7 | 6657_UP | |
| Drug | Ampicillin trihydrate [7177-48-2]; Down 200; 10uM; PC3; HT_HG-U133A | 4.23e-05 | 198 | 107 | 7 | 6307_DN | |
| Drug | nordihydroguaiaretic acid; Up 200; 1uM; HL60; HT_HG-U133A | 4.37e-05 | 199 | 107 | 7 | 6182_UP | |
| Drug | DL-penicillamine | 5.06e-05 | 139 | 107 | 6 | CID000004727 | |
| Drug | Madecassol | 6.46e-05 | 46 | 107 | 4 | CID000108062 | |
| Disease | Disproportionate short stature | 1.01e-08 | 77 | 103 | 7 | C0878659 | |
| Disease | chondrosarcoma (is_marker_for) | 1.21e-05 | 2 | 103 | 2 | DOID:3371 (is_marker_for) | |
| Disease | Spondyloepiphyseal Dysplasia | 2.24e-05 | 16 | 103 | 3 | C0038015 | |
| Disease | Spondyloepiphyseal Dysplasia Tarda, X-Linked | 2.24e-05 | 16 | 103 | 3 | C3541456 | |
| Disease | Schwartz-Jampel Syndrome, Type 1 | 2.24e-05 | 16 | 103 | 3 | C4551479 | |
| Disease | Schwartz-Jampel Syndrome | 2.24e-05 | 16 | 103 | 3 | C0036391 | |
| Disease | Melnick-Needles Syndrome | 2.24e-05 | 16 | 103 | 3 | C0025237 | |
| Disease | Van Buchem disease | 2.71e-05 | 17 | 103 | 3 | C0432272 | |
| Disease | Osteochondrodysplasias | 3.84e-05 | 19 | 103 | 3 | C0029422 | |
| Disease | Dyschondroplasias | 3.84e-05 | 19 | 103 | 3 | C0013366 | |
| Disease | Multiple Epiphyseal Dysplasia | 4.51e-05 | 20 | 103 | 3 | C0026760 | |
| Disease | age at menopause | 9.40e-05 | 302 | 103 | 7 | EFO_0004704 | |
| Disease | Williams Syndrome | 3.33e-04 | 8 | 103 | 2 | C0175702 | |
| Disease | diffuse large B-cell lymphoma (is_marker_for) | 3.33e-04 | 8 | 103 | 2 | DOID:0050745 (is_marker_for) | |
| Disease | Malignant neoplasm of breast | KLK15 EVL COL11A1 DYNC2H1 SH2D3A TRMT11 MANEA CNTN6 LLGL2 NHS VPS13B DNMT3B | 3.70e-04 | 1074 | 103 | 12 | C0006142 |
| Disease | age at menarche | 1.15e-03 | 594 | 103 | 8 | EFO_0004703 | |
| Disease | interleukin 10 measurement | 2.60e-03 | 78 | 103 | 3 | EFO_0004750 | |
| Disease | pulmonary hypertension (biomarker_via_orthology) | 2.79e-03 | 80 | 103 | 3 | DOID:6432 (biomarker_via_orthology) | |
| Disease | Hereditary Paraganglioma-Pheochromocytoma Syndrome | 2.91e-03 | 23 | 103 | 2 | C1708353 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PLGKHYSQRWAQEDL | 191 | O75528 | |
| DRVDSWTPFYQRGHN | 106 | P78357 | |
| VSAAHRARYFWGNLP | 726 | Q9UBC3 | |
| QWKATHRRLYGANEE | 31 | O60911 | |
| FNNEPWVRGRHETYL | 206 | Q9HC16 | |
| TPIGTDRNHNRYWLF | 901 | Q9UIG0 | |
| RNWRKSGPTSYLHQI | 131 | Q5T686 | |
| SPQENPWGHKRTYRL | 581 | P19801 | |
| GQERWQKDYNHLPTG | 81 | Q99766 | |
| EDWQHFPRYRTASQG | 1276 | Q9NZN5 | |
| RRKPDQWAQYHTQKA | 776 | Q9HBD1 | |
| VTWYKRGGSLPARHQ | 2276 | P98160 | |
| VTWYKRGGSLPARHQ | 2956 | P98160 | |
| KASYRLHQLRSWGAP | 921 | Q9ULG1 | |
| AAYNVDQHRKPRGWS | 221 | A8MYP8 | |
| IKARSGDNPVYIWGH | 231 | Q8N2K0 | |
| HIRTYKQRDPGIFAW | 86 | P55771 | |
| QDQEGYRWKGHERLA | 551 | Q6P1M3 | |
| DISPVDNHRYKWNGR | 126 | Q8IWI9 | |
| RIPWKHAGKQDYNRE | 51 | Q15306 | |
| KHSGSWPGHRYRDQQ | 676 | Q9P266 | |
| DLAWLYPGRRDKQHF | 136 | P36222 | |
| YPLFRTVNIADGKWH | 151 | P12107 | |
| NENWKRHSYAGEQPE | 381 | Q5T0W9 | |
| HSQPWQVALYERGRF | 31 | Q9H2R5 | |
| VKRSWPDYVEENRGH | 296 | Q9C000 | |
| PKDRALYAWNNGHQI | 456 | Q99784 | |
| PTFHQWRDARQVYGL | 76 | Q9UI08 | |
| NSWVPHEGRSKRNYN | 296 | Q6ZU52 | |
| AQYLWFHRRSLPGKA | 11 | Q86XA0 | |
| RNKNVPVNHRDFWYA | 496 | Q96RT8 | |
| GVLSWYRKQPDAVHN | 261 | Q9BXW6 | |
| YRRKFPAWQNSIRHN | 141 | Q12950 | |
| WDPRIAKNYPQGRHN | 131 | Q5SRI9 | |
| WRKDGAVLAGNHARY | 3746 | Q96RW7 | |
| RSKRWLPSHVYVNQG | 276 | Q86YD1 | |
| LKGQPGDIYHQTWAR | 236 | P04062 | |
| RGDYDAPTHQVQWQA | 56 | Q9Y3R4 | |
| PNADAYFTKRKWGQH | 586 | Q58A45 | |
| AEHLRGWYQRASGQK | 896 | Q9Y2L6 | |
| HAACQERRNYIPQGW | 3871 | Q8NCM8 | |
| GYPARSHFWDNSKER | 591 | Q16394 | |
| NRWHEGYRQTPKEDS | 406 | P16070 | |
| NVRWDHAEGNPRQYK | 1861 | Q99715 | |
| DSYPNWLKFHIGINR | 221 | Q8IXL6 | |
| VNWTHAPGNVEKYRV | 371 | Q05707 | |
| YRVWNSNKHPALAEI | 546 | Q8NBF6 | |
| TSWHQRGQNPGKSYR | 686 | O75128 | |
| ARKPHYDIWGNTVNV | 1056 | O60266 | |
| PSPHYRWKQNGTDID | 56 | Q9UQ52 | |
| WELPHAYKRSDQRGA | 416 | Q674R7 | |
| FWSDRRNPHEVQPAY | 366 | Q9GZT9 | |
| NAYRLHWQGREEPGA | 81 | Q96KT0 | |
| WNSSNPRFQRGDYHI | 36 | P52803 | |
| KAFYNESWERRHGRP | 86 | Q9NRM0 | |
| SHWHKLYPIAQGDRQ | 16 | P43166 | |
| WSDRRNPHEVKPAYA | 351 | Q96KS0 | |
| HRYEQGRFWPHLKAS | 276 | Q9UBN7 | |
| GWQYGPVRDDNKRQH | 901 | Q92736 | |
| KAQRWHQGNEHYGRS | 1141 | Q92736 | |
| YRQPRKAIAWHHSGP | 951 | A6NGG8 | |
| AKAGPTARNRYASQW | 1736 | O60469 | |
| RGSYQGWKNSVRHNL | 86 | Q12946 | |
| ANHLSPQALKWREYR | 886 | Q8N2Y8 | |
| RPDYTAQNLDHGKAW | 101 | P82930 | |
| APGWKQYLEQHASGR | 41 | Q5QGT7 | |
| FGRNWLQYRSHLEPS | 426 | Q8N1F8 | |
| PHNIYFGRWIADGQR | 166 | Q7Z4G4 | |
| HPSWPRLDRNNSKGY | 416 | Q86VY9 | |
| GENETYPRALLHWNR | 606 | Q9UBV2 | |
| YPRALLHWNRAASQG | 611 | Q9UBV2 | |
| WQDYLDHKRQGRPSI | 826 | Q6T4R5 | |
| NARERIVGWYHTGPK | 86 | P51665 | |
| DHYAQLKRENPNWSV | 106 | Q8WW32 | |
| YGNSHRTGKDNWLER | 871 | Q96Q15 | |
| LNKLRARHAQGGTWY | 461 | Q99832 | |
| AYQRALAAHPWKVQV | 6 | P39210 | |
| SNWMRYVNPAHSPRE | 156 | O75626 | |
| NRLWNPHLRGYSSGK | 3356 | Q9P2P6 | |
| RYWGKAAAAASREHP | 41 | A6NJG2 | |
| HLGGPNTLKWDYTRQ | 191 | Q8NA69 | |
| AHRKPEAVVLEGNYW | 156 | Q9NP71 | |
| SGPAVYFWRHRKQAD | 576 | P36956 | |
| HSYWTLKRQSRNGVP | 541 | P55201 | |
| RRQWKHIYDELGGNP | 371 | Q14865 | |
| VQNGLRYHDRDVWKP | 41 | P02452 | |
| YRPWKHAEGQLSFIQ | 396 | A5YKK6 | |
| KGSLRQQANHPYWAD | 351 | O95985 | |
| SRHWNEGKQAGYSLP | 2651 | Q86UP3 | |
| DRWQYGDSAVGRHRK | 71 | P98170 | |
| WGDPNYRSANFREHI | 181 | Q9Y508 | |
| AGQPWYHGLLSRQKA | 11 | Q9BRG2 | |
| NARDNWNYTPLHEAA | 276 | O95271 | |
| YETPTAHNGAKNPRW | 86 | Q9H0E2 | |
| RRDASQHPDPAWYQT | 66 | O60504 | |
| WYQDGQQRLDAHSIP | 1121 | Q9BZZ2 | |
| DVQYSHTPNKAGFRW | 2776 | Q86WI1 | |
| AEWYHEGNVKTRPSN | 306 | Q8IYW5 | |
| LRHGADPNARDNWNY | 111 | Q9H2K2 | |
| VAWGQEYLKTHPAGR | 666 | O15195 | |
| ANNHPAAYWQREERF | 56 | Q9P2E3 | |
| AFHAKRSYQPHGRWA | 851 | O43379 | |
| RSYQPHGRWAERAGQ | 856 | O43379 | |
| WHAAYPAQAQSSRER | 6 | P59923 | |
| EEWGQLAPAHRNLYR | 86 | Q9UJL9 | |
| REQEYKSWGSFHQNP | 161 | Q96NI8 | |
| SFREPHMYLRQWNNG | 2526 | Q7Z7G8 | |
| AALENYHPRTGLKWQ | 491 | Q8TDI7 | |
| EKQPWYHGAISRAEA | 391 | Q5VZ18 | |
| AKNWHLLGEPYRSER | 2636 | Q6ZQQ6 | |
| HQQGYPRKWRTDDAP | 856 | Q9HBA0 | |
| KGLQHPNIVRFYDSW | 226 | Q96J92 | |
| CNAHIRYFGKRPQWD | 221 | Q5FWF4 | |
| GNHRDNKAVIRYLPW | 2376 | Q9P2D8 |